Strategic Deals Drive TEM Growth Amid Competition: Buy, Hold or Sell?

Key Takeaways Tempus AI expands through the $81.25M Paige deal, following its Deep 6 AI acquisition. New launches like xM, Fuses, and Loop strengthen TEM's AI-driven diagnostics portfolio. TEM's net loss narrowed sharply as gross profit surged 160% and EBITDA improved in Q2 2025. Tempus AI, Inc. (TEM) continues to strengthen its position in precision medicine through strategic acquisitions. In a move to expand its digital pathology capabilities, the company announced the $81.25 million acquisition of Paige, ...